Adapt Investment Managers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60M Hold
50,000
0.48% 31
2026
Q1
$46M Buy
50,000
+12,500
+33% +$12.7M 0.61% 31
2025
Q4
$40.3M Hold
37,500
0.3% 52
2025
Q3
$28.6M Buy
+37,500
New +$27.9M 0.27% 57

Other funds holding LLY

Adapt Investment Managers's LLY Position: Q2 2026 in Review

Adapt Investment Managers sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 15,873 shares — an estimated $16.2M sold.

Adapt Investment Managers first reported a position in LLY in Q3 2025 and held it in 2 quarters. The position peaked at $14.6M in Q1 2026. 1,682 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Adapt Investment Managers reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Adapt Investment Managers sold 15,873 Eli Lilly shares in Q2 2026, an estimated $16.2M.
  • Adapt Investment Managers first reported a position in Eli Lilly in Q3 2025 and held it in 2 quarters.
  • Adapt Investment Managers's Eli Lilly position peaked at $14.6M in Q1 2026.
  • 1,682 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Adapt Investment Managers's 13F filing for Q2 2026, filed 27 Jul 2026.